BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 97 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $119,820,000 | -21.9% | 35,555 | +42.8% | 0.00% | – |
| Q3 2018 | $153,384,000 | -16.5% | 24,900 | 0.0% | 0.00% | – |
| Q2 2018 | $183,762,000 | +20.7% | 24,900 | +7.3% | 0.00% | – |
| Q1 2018 | $152,192,000 | +72719.1% | 23,200 | +121.0% | 0.00% | – |
| Q3 2016 | $209,000 | +53.7% | 10,500 | 0.0% | 0.00% | – |
| Q2 2016 | $136,000 | +38.8% | 10,500 | 0.0% | 0.00% | – |
| Q1 2016 | $98,000 | -95.3% | 10,500 | -88.3% | 0.00% | -100.0% |
| Q1 2015 | $2,078,000 | -0.6% | 89,700 | -1.1% | 0.00% | 0.0% |
| Q4 2014 | $2,090,000 | – | 90,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |